An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)

Oncotarget
Yasumasa EzoeManabu Muto

Abstract

Hyponatremia is a common electrolyte abnormality in cancer patients who receive chemotherapy. Among anticancer agents, platinum-based agents are reported to cause chemotherapy-induced hyponatremia. However, the actual incidence and risk factors remain unknown. The reports of 29 trials were analyzed. The incidence of grade 3/4 hyponatremia was 11.9% in patients treated with platinum-based chemotherapy and 3.8% in those treated with nonplatinum-based regimens (P< 0.01). Univariable analysis revealed a high incidence of hyponatremia in patients receiving cisplatin, three-drug combination regimen, two-drug combination regimen with amrubicin or irinotecan, or high-dose cisplatin (weekly equivalent cisplatin dose ≥20 mg/m2), and in patients with small-cell lung cancer. This is the first report of the actual incidence and the potential risk factors of chemotherapy-induced hyponatremia. Careful monitoring of serum sodium level is needed when platinum-based chemotherapy is administered. This study included all clinical trials of systemic chemotherapies for solid cancers that were conducted by the Japan Clinical Oncology Group (JCOG) after January 2000 and of which the patient enrolment was completed by January 2014. The latest reports o...Continue Reading

References

Jun 15, 1987·Biochemical Pharmacology·Z H SiddikK R Harrap
Feb 1, 1985·Annals of Internal Medicine·R J AndersonR W Schrier
Sep 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T Berghmans
May 2, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T BerghmansJ J Body
May 29, 2000·The New England Journal of Medicine·H J Adrogué, N E Madias
Oct 19, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S L VanheesJ F Vansteenkiste
Aug 19, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Harry Raftopoulos
May 13, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·George LiamisMoses Elisaf
Aug 1, 2009·The British Journal of Surgery·T YoshikawaN Fukushima
Feb 27, 2010·Japanese Journal of Clinical Oncology·Hiroshi IshiiUNKNOWN JCOG Gastrointestinal Oncology Study Group
Jan 21, 2011·Japanese Journal of Clinical Oncology·Takaaki ChouUNKNOWN Lymphoma Study Group (LSG) of Japan Clinical Oncology Group (JCOG), Japan
Sep 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takashi WatanabeTomomitsu Hotta
Nov 10, 2011·Toxins·Ronald P MillerWilliam Brian Reeves
May 24, 2012·The Oncologist·Jorge J CastilloEric Justice
Feb 13, 2013·Journal of Surgical Oncology·Yoshiaki IwasakiUNKNOWN Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group
Sep 10, 2013·Japanese Journal of Clinical Oncology·Kuniaki ShiraoUNKNOWN Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Feb 18, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Haruyasu MurakamiTomohide Tamura
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Miyako SatouchiNagahiro Saijo
Mar 26, 2014·European Journal of Cancer Care·G F Abu ZeinahA Allam
Mar 29, 2014·The British Journal of Surgery·A TsuburayaUNKNOWN Stomach Cancer Study Group of the Japan Clinical Oncology Group
Mar 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H KitamuraUNKNOWN Urologic Oncology Study Group of the Japan Clinical Oncology Group
Jun 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yasuhiro ShimadaYoshihiro Moriya
Jul 22, 2014·Cancer Science·Shuichi HironakaUNKNOWN Japan Esophageal Oncology Group/Japan Clinical Oncology Group
Nov 8, 2014·Japanese Journal of Clinical Oncology·Hiroko TsukadaUNKNOWN Lung Cancer Study Group of the Japan Clinical Oncology Group (JCOG)
Mar 4, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryo KitagawaHiroyuki Yoshikawa
Sep 21, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Tomohiro NishinaUNKNOWN Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Apr 14, 2016·Critical Reviews in Oncology/hematology·Rossana BerardiStefano Cascinu

❮ Previous
Next ❯

Citations

Nov 7, 2019·Biological & Pharmaceutical Bulletin·Shiro HatakeyamaHiroaki Yamaguchi
Oct 30, 2020·European Endocrinology·Aishwarya KrishnamurthyDeep Dutta
Jun 30, 2021·Clinical and Translational Medicine·Devasier BennetFrederic Zenhausern
Nov 16, 2021·Frontiers in Oncology·Christina SalvadorRoman Crazzolara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.